HSIC|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.23 | - | - |
| Q1'26 | $1.22 | $1.32 | +8.4% |
| Q4'25 | $1.26 | $1.34 | +6.3% |
| Q3'25 | $1.28 | $1.38 | +7.9% |
| Q2'25 | $1.19 | $1.10 | -7.6% |
| Q1'25 | $1.11 | $1.15 | +3.6% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $3.4B | - | - |
| Q1'26 | $3.4B | $3.4B | -0.2% |
| Q4'25 | $3.3B | $3.4B | +3.1% |
| Q3'25 | - | $3.3B | - |
| Q2'25 | - | $3.2B | - |
| Q1'25 | - | $3.2B | - |
Market Data
HSIC Stock Snapshot
HSIC is currently trading at $74.24, giving Henry Schein, Inc. a market cap of 8.45B and a P/E ratio of 21.4. Today's range spans $73.83–$74.25, with shares opening at $74.25 and moving up $0.03 (0.0%) from the prior close. DailyIQ's technical score sits at 36/100 (HOLD) with a news sentiment reading of 64/100.
Over the past year HSIC has traded between $61.95 and $89.29 - the current price is +19.8% off the 52-week low and -16.9% from the high.
The data doesn't make a strong case for HSIC right now: 36/100 technical score (HOLD), bullish sentiment (64/100), price $74.24 (in the middle of its 52-week range). The current P/E ratio stands at 21.4. For a small-cap with 8.45B in Healthcare market cap, this kind of setup often leads to rangebound or drifting price action - the kind of environment where holding the stock has opportunity cost and the exit is easier said than done in thin markets. Annual range: $61.95–$89.29.
For HSIC (small-cap, Healthcare, 8.45B market cap), the HOLD technical reading (36/100) and bullish news sentiment (64/100) at $74.24 (in the middle of its 52-week range) describe a stock where the cost of patience is higher than in large-cap equivalents — thin float dynamics mean that time spent waiting for a catalyst can erode position value without the passive bid support that larger names receive. The $61.95–$89.29 annual range defines the structural stakes.
Recent News Coverage
Most recent articles, ranked by recency (click to expand).